ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034)

ClinicalTrials.gov ID: NCT03654326

Public ClinicalTrials.gov record NCT03654326. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 8, 2026, 3:47 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2a, Proof of Concept, Randomized, Double-Blind, Placebo-Controlled Clinical Trial, to Evaluate the Efficacy and Safety of MK-7264 in Women With Moderate to Severe Endometriosis-Related Pain

Study identification

NCT ID
NCT03654326
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Merck Sharp & Dohme LLC
Industry
Enrollment
187 participants

Conditions and interventions

Interventions

  • Gefapixant Drug
  • Naproxen Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 49 Years
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 10, 2018
Primary completion
Jun 29, 2020
Completion
Jun 29, 2020
Last update posted
Nov 3, 2024

2018 – 2020

United States locations

U.S. sites
30
U.S. states
14
U.S. cities
28
Facility City State ZIP Site status
Cahaba Medical Care ( Site 0750) Birmingham Alabama 35218
Synexus US Phoenix Southeast ( Site 0729) Chandler Arizona 85224
Synexus ( Site 0734) Scottsdale Arizona 85251
Lynn Institute of the Ozarks ( Site 0720) Little Rock Arkansas 72205
California Center for Clinical Research ( Site 0741) Arcadia California 91007
Artemis Institute for Clinical Research ( Site 0716) San Diego California 92103
Alta California Medical Group ( Site 0721) Simi Valley California 93065
Thameside OBGYN Center ( Site 0747) Groton Connecticut 06340
WHUSA Fine and Gillette ( Site 0751) Hamden Connecticut 06518
Florida Fertility Institute ( Site 0737) Clearwater Florida 33759
Advanced Pharma Research ( Site 0719) Cutler Bay Florida 33189
Doral Medical Research, LLC ( Site 0706) Doral Florida 33166
KO Clinical Research, LLC ( Site 0723) Fort Lauderdale Florida 33316
Well Pharma Medical Research, Corp. ( Site 0703) Miami Florida 33143
L&C Professional Medical Research Institute ( Site 0709) Miami Florida 33144
New Horizon Research Center ( Site 0717) Miami Florida 33465
Inpatient Research Clinic, LLC ( Site 0725) Miami Lakes Florida 33014
QPS Miami Research Associates ( Site 0735) South Miami Florida 33143
Lenus Research & Medical Group Llc ( Site 0702) Sweetwater Florida 33172
Southern Clinical Research Associates ( Site 0701) Metairie Louisiana 70001
Tufts Medical Center ( Site 0742) Boston Massachusetts 02111
Carolina Women's Research and Wellness Center ( Site 0715) Durham North Carolina 27713
Palmetto Clinical Research ( Site 0707) Summerville South Carolina 29485
Chattanooga Medical Research ( Site 0743) Chattanooga Tennessee 37404
Women Partners in Health ( Site 0745) Austin Texas 78705
Corpus Christi Clinic ( Site 0744) Corpus Christi Texas 78412
HD Research Corp ( Site 0738) Houston Texas 77024
PI-Coor Clinical Research, LLC ( Site 0710) Reston Virginia 20190
Clinical Research Partners, LLC. ( Site 0704) Richmond Virginia 23225
Seattle Women's: Health, Research, Gynecology ( Site 0714) Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03654326, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 3, 2024 · Synced May 8, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03654326 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →